Commercialization of Products. From and after the Effective Date, BMS shall have the sole right to Commercialize the Product in the Field in the Territory during the Royalty Term at its cost and expense. During the Royalty Term, BMS will use Diligent Efforts to Commercialize a Product in each Major Market for which BMS receives Regulatory Approval for such Product.
Commercialization of Products. Promptly after obtaining Regulatory Approval for the Product in the Exclusive Territory from the applicable Regulatory Authority, the Parties will mutually agree on launch dates for the Commercialization of the Products in the Exclusive Territory.
Commercialization of Products. Astellas shall have sole responsibility for planning, coordinating, monitoring, and regulating all aspects of the promotion, marketing, distribution, sales and other commercialization activities of each Product in all countries in the Territory, except that, solely with respect to promotion of each Co-Promoted Product in the U.S. during the applicable Co-Promotion Term, each Party shall have the responsibility set forth herein and in the Co-Promotion Agreement. Astellas shall be responsible for all costs associated with the activities for which it is solely responsible, except to the extent they relate to a Co-Promoted Product and constitute Allowed Expenses.
Commercialization of Products. The Parties agree and acknowledge that the Company will Commercialize, and develop a Commercialization strategy for all Products (including Products containing HMPL-004 or other Products that the Company has the right to Commercialize pursuant to any other agreement between it and Xxxxxxxxx or an Affiliate of Xxxxxxxxx) in their respective Fields, subject to the License Agreements and any other contractual undertakings of the Company from time to time. Such Commercialization strategy may result in the out-licensing of the Commercialization rights to the relevant Products in the Field to one or more Third Party providers if the Board deems such out-license to be in the Company’s best interest. Subject to Section 15.2, the Parties agree that prior to approaching any Third Party, the Company will discuss in good faith with Nestlé the terms upon which Nestlé may license the Commercialization rights to the relevant Products in the relevant Field but in no event will the Company be obliged to enter into such license.
Commercialization of Products. As of the Closing Date, Buyer shall be solely and exclusively responsible for the manufacture, Development and Commercialization of the Products, including all decisions pertaining to such manufacture, Development or Commercialization, including any recall of Products.
Commercialization of Products. No later than *************** of completion of each project set forth in the Research Program, the parties shall meet and negotiate and agree upon a *************** for the Product resulting from each project, the terms of which shall be set forth in a ***************. If the parties are unable to reach agreement for any Product, the matter shall be resolved in accordance with Section 6.2 herein.
Commercialization of Products. BMS shall have the sole right and responsibility for the Commercialization of Products in the Field in the Territory during the Term at its cost and expense. During the Term, BMS will use Diligent Efforts to Commercialize a Product for each Collaboration Target in the Major Markets for which BMS receives Regulatory Approval for such Product.
Commercialization of Products. Subject only to the terms and conditions applying to the Opt-In Product, Genmab shall have all rights and responsibilities, and shall bear all costs associated with, the Commercialization of Products and will book all sales of Products. Genmab will use Commercially Reasonable Efforts to Commercialize each Products in the Major Market Countries where it obtains Regulatory Approval. In addition to the royalty reports provided by Genmab to CureVac under Section 10.6, beginning with the First Commercial Sale of the first Product and continuing, on a Product-by-Product basis, until expiry of the last Valid Claim, Genmab shall provide CureVac, at least [*****] with a written report summarizing the current status of, estimated timeline and high-level commercialization plans for the Commercialization of any Products.
Commercialization of Products. From and after the License Effective Date, BMS (by itself or through its Affiliates, Sublicensees, contractors or agents, as applicable) shall ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(2), (4), (5) and (6) and 230.406 use Diligent Efforts to have a First Commercial Sale of a Product in each Major Market within [***] after BMS receives both Regulatory Approval and pricing and reimbursement approvals acceptable to BMS necessary for the sale of the Product in such Major Market, and thereafter Commercialize such Product in such Major Market. Without prejudice to the foregoing, (i) BMS shall use its Diligent Efforts to Commercialize the Product in accordance with the portion of the then-current Commercialization and Development Plan covering the then-current Calendar Year and (ii) BMS (by itself or through its Affiliates) shall have sole right, including sole responsibility for all funding, resourcing and decision-making, for all Commercialization activities with respect to the Products. BMS shall perform such Commercialization activities in compliance with all Applicable Laws.
Commercialization of Products. To the actual knowledge of the Key JT Personnel there are no Patents (other than the JT Patents) that would be infringed by the manufacture, development, use, sale, offer for sale or importation of Compound for treating HIV infection in the Gilead Expanded Territory.
